Abstract
A 73-year-old Japanese woman, with a history of Sweet syndrome diagnosed 3 years earlier and anti-myeloperoxidase (MPO) antibody anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis diagnosed 1 year earlier, presented with an episode of rapidly progressive glomerulonephritis (RPGN) with anti-glomerular basement membrane (GBM) disease. At the time of diagnosis of the ANCA-associated vasculitis 1 year earlier, serological testing yielded a negative result for anti-GBM antibody. However, at the present visit, serology for anti-MPO antibody was negative, while that for anti-GBM antibody was positive. This is the first report of anti-GBM disease developing sequentially after Sweet syndrome and ANCA-associated vasculitis. This case may provide clues to the potential immunological links among these three distinct conditions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
McAdoo SP, Pusey CD. Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol. 2017;12:1162–72.
Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int. 2004;66:1535–40.
Le Moine C, Jourde-Chiche N, Kemlin D, Terrier B, Vandergheynst F. Sequential development of ANCA-associated vasculitis and anti-GBM disease: a report of two cases. Clin Case Rep. 2021;9:04553.
Arun Kumar AU, Elsayed ME, Alghali A, Ali AA, Mohamed H, Hussein W, Hackett C, Leonard N, Stack AG. Sweet syndrome: a rare feature of ANCA-associated vasculitis or unusual consequence of azathioprine-induced treatment. Allergy Asthma Clin Immunol. 2018;14:46.
Suppiah R, Robson JC, Grayson PC, Ponte C, Craven A, Khalid S, Judge A, et al. 2022 American college of rheumatology/European alliance of associations for rheumatology classification criteria for microscopic polyangiitis. Ann Rheum Dis. 2022;81:321–6.
Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66(2):222–7.
JayneDR MarshallPD. Jones SJ, Lockwood CM: autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int. 1990;37:965–70.
Rutgers A, Slot M, van Paassen P, van Breda VP, Heeringa P, Tervaert JW. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis. 2005;46:253–62.
Wahls TL, Bonsib SM, Schuster VL. Coexistent Wegener’s granulomatosis and anti-glomerular basement membrane disease. Hum Pathol. 1987;18:202–5.
Serratrice J, Chiche L, Dussol B, Granel B, Daniel L, Jego-Desplat S, Disdier P, Swiader L, Berland Y, Weiller PJ. Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis. 2004;43:e26-30.
Chan PS, Leung MH. Sequential occurrence of anti-glomerular basement membrane disease 9 years after anti-neutrophil cytoplasmic antibody-associated vasculitis. Oxf Med Case Rep. 2016;2016(4):91–3.
Gallagher JL, Sinha S, Reeve R, Kalra PA. Importance of checking anti-glomerular basement membrane antibody status in patients with anti-neutrophil cytoplasmic antibody-positive vasculitis. Postgrad Med J. 2008;84:220–2.
Olson SW, Arbogast CB, Baker TP, Owshalimpur D, Oliver DK, Abbott KC, Yuan CM. Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. J Am Soc Nephrol. 2011;22:1946–52.
Li JN, Cui Z, Wang J, Hu SY, Jia XY, Guan Z. ChenM, Xie C, Zhao MH: autoantibodies against linear epitopes of myeloperoxidase in anti-glomerular basement membrane disease. Clin J Am Soc Nephrol. 2016;11:568–75.
Kosumi H, Watanabe M, Natsuga K, Miyauchi T, Shiiya C, Ujiie H, Shimizu H. Sweet’s syndrome mimicking anti-neutrophil cytoplasmic antibodies-associated vasculitis. Am J Med. 2018;131:e241–2.
Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med. 1997;126:866–73.
de Boysson H, Martin Silva N, de Moreuil C, Néel A, de Menthon M, Meyer O, Launay D, Pagnoux C, Guillevin L, Puéchal X, Bienvenu B, Aouba A, French Vasculitis Study Group, French Internal Medicine Society. Neutrophilic dermatoses in antineutrophil cytoplasmic antibody-associated vasculitis: a french multicenter study of 17 cases and literature review. Medicine (Baltimore). 2016;95:2957.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared that no conflicts of interest exists.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Matsuno, S., Itabashi, M., Komatsu, A. et al. Anti-glomerular basement membrane disease developing 3 years after the development of Sweet syndrome and 1 year after the development of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report. CEN Case Rep 12, 259–264 (2023). https://doi.org/10.1007/s13730-022-00758-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13730-022-00758-3